Celldex Therapeutics, Inc. planned insider sales
In the last twelve months insiders at Celldex Therapeutics, Inc. filed 2 Form 144 notices of planned sales, 53,464 shares worth $1.3 million at the time of filing, from 2 sellers. The latest, filed 4 December 2025: Freddy A Jimenez (officer), 4,166 shares worth $121,210, planned for around 4 December 2025 through Morgan Stanley Smith Barney LLC Executive Financial Services.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 4 December 2025 | Freddy A Jimenez | Officer | 4,166 | $121,210 | 4 December 2025 | 4,166 shares from 4 December 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercised Shares | Form 144 |
| 13 November 2025 | Richard M Wright | Officer | 49,298 | $1.2 million | 13 November 2025 | 49,298 shares from 13 November 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.